BMC Research Notes (Oct 2018)

Methylation analysis of HOXA10 regulatory elements in patients with endometriosis

  • Pietro G. Signorile,
  • Anna Severino,
  • Massimo Santoro,
  • Maria Spyrou,
  • Rosa Viceconte,
  • Alfonso Baldi

DOI
https://doi.org/10.1186/s13104-018-3836-1
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 5

Abstract

Read online

Abstract Objective The pathogenesis of endometriosis is still mysterious, being retrograde menstruation and coelomic metaplasia the most accepted hypotheses. Recently, it has been proposed that endometriosis is caused by fine-tuning alterations of the female genital system development during the foetal life and that in utero exposition to endocrine disruptors can be one of the factors causing the disease, possibly acting on the methylation status of the genome. In this study, we have evaluated the methylation status of HOXA10 gene regulation regions in a cohort of 22 endometriosis patients respect to a control group of 6 healthy women. Results The methylation study was carried out on three CpG islands, previously described hypermethylated in the endometrium of endometriosis patients and include 22 CpG sites, 21 CpG sites and 10 CpG sites, respectively identified through the online platform MethPrimer. The analysis did not find significant differences between patients with endometriosis and healthy control individuals. These results confirm previous studies on genome wide methylation analysis in endometriosis patients. Therefore, other epigenetically altered genes should be considered more related to the pathogenesis of endometriosis.

Keywords